-
2
-
-
67650874081
-
Cancer statistics
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009.CA Cancer J Clin 59: 225-249.
-
(2009)
2009.CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
-
3
-
-
73949141005
-
Fulfilling the promise of personalized medicine? Systematic review and fieldsynopsis of pharmacogenetic studies
-
Holmes MV, Shah T, Vickery C, Smeeth L, Hingorani AD, et al. (2009) Fulfilling the promise of personalized medicine? Systematic review and fieldsynopsis of pharmacogenetic studies. PLoS One 4: e7960.
-
(2009)
PLoS One
, vol.e7960
, pp. 4
-
-
Holmes, M.V.1
Shah, T.2
Vickery, C.3
Smeeth, L.4
Hingorani, A.D.5
-
4
-
-
58749084711
-
The molecular basis of cancer and the developmentof targeted therapy
-
Riley LB, Desai DC (2009) The molecular basis of cancer and the developmentof targeted therapy. Surg Clin North Am 89: 1-15, 7.
-
(2009)
Surg Clin North Am
, vol.1-15
, Issue.7
, pp. 89
-
-
Riley, L.B.1
Desai, D.C.2
-
5
-
-
62249157059
-
An introduction to molecular targeted therapy ofcancer
-
Allgayer H, Fulda S (2008) An introduction to molecular targeted therapy ofcancer. Adv Med Sci 53: 130-138.
-
(2008)
Adv Med Sci
, vol.53
, pp. 130-138
-
-
Allgayer, H.1
Fulda, S.2
-
6
-
-
11144242211
-
Timeline: Chemotherapy and the war oncancer
-
Chabner BA, Roberts TG, Jr. (2005) Timeline: Chemotherapy and the war oncancer. Nat Rev Cancer 5: 65-72.
-
(2005)
Nat Rev Cancer
, vol.5
, pp. 65-72
-
-
Chabner, B.A.1
Roberts Jr., T.G.2
-
7
-
-
41649114164
-
Enabling personalized cancer medicinethrough analysis of gene-expression patterns
-
van't Veer LJ, Bernards R (2008) Enabling personalized cancer medicinethrough analysis of gene-expression patterns. Nature 452: 564-570.
-
(2008)
Nature
, vol.452
, pp. 564-570
-
-
Van't veer, L.J.1
Bernards, R.2
-
8
-
-
64249135764
-
Novel agents on the horizon for cancer therapy
-
Ma WW, Adjei AA (2009) Novel agents on the horizon for cancer therapy. CACancer J Clin 59: 111-137.
-
(2009)
CACancer J Clin
, vol.59
, pp. 111-137
-
-
Ma, W.W.1
Adjei, A.A.2
-
9
-
-
35348874847
-
Personalized medicine in the era of genomics
-
Burke W, Psaty BM (2007) Personalized medicine in the era of genomics. Jama298: 1682-1684.
-
(2007)
Jama298
, pp. 1682-1684
-
-
Burke, W.1
Psaty, B.M.2
-
10
-
-
70449487356
-
Personalized medicine: Individualized care of cancer patients
-
Ely S (2009) Personalized medicine: individualized care of cancer patients Transl Res 154: 303-308.
-
(2009)
Transl Res
, vol.154
, pp. 303-308
-
-
Ely, S.1
-
11
-
-
70449465250
-
Genomic and personalized medicine:Foundations and applications
-
Ginsburg GS, Willard HF (2009) Genomic and personalized medicine:foundations and applications. Transl Res 154: 277-287.
-
(2009)
Transl Res
, vol.154
, pp. 277-287
-
-
Ginsburg, G.S.1
Willard, H.F.2
-
12
-
-
67650617779
-
Educating for personalized medicine: Aperspective from oncology
-
Parkinson DR, Ziegler J (2009) Educating for personalized medicine: aperspective from oncology. Clin Pharmacol Ther 86: 23-25.
-
(2009)
Clin Pharmacol Ther
, vol.86
, pp. 23-25
-
-
Parkinson, D.R.1
Ziegler, J.2
-
13
-
-
70449513464
-
Back to the future: Why randomized controlled trials cannot bethe answer to pharmacogenomics and personalized medicine
-
Frueh FW (2009) Back to the future: why randomized controlled trials cannot bethe answer to pharmacogenomics and personalized medicine. Pharmacogenomics10: 1077-1081.
-
(2009)
Pharmacogenomics10
, pp. 1077-1081
-
-
Frueh, F.W.1
-
14
-
-
77349095483
-
Modeling complex workflow inmolecular diagnostics: Design specifications of laboratory software for support ofpersonalized medicine
-
Gomah ME, Turley JP, Lu H, Jones D (2010) Modeling complex workflow inmolecular diagnostics: design specifications of laboratory software for support ofpersonalized medicine. J Mol Diagn 12: 51-57.
-
(2010)
J Mol Diagn
, vol.12
, pp. 51-57
-
-
Gomah, M.E.1
Turley, J.P.2
Lu, H.3
Jones, D.4
-
15
-
-
33747855481
-
Comparing antibody and small-molecule therapiesfor cancer
-
Imai K, Takaoka A (2006) Comparing antibody and small-molecule therapiesfor cancer. Nat Rev Cancer 6: 714-727.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 714-727
-
-
Imai, K.1
Takaoka, A.2
-
16
-
-
31144459985
-
Oncogenic pathwaysignatures in human cancers as a guide to targeted therapies
-
Bild AH, Yao G, Chang JT, Wang Q, Potti A, et al. (2006) Oncogenic pathwaysignatures in human cancers as a guide to targeted therapies. Nature 439: 353-357.
-
(2006)
Nature
, vol.439
, pp. 353-357
-
-
Bild, A.H.1
Yao, G.2
Chang, J.T.3
Wang, Q.4
Potti, A.5
-
17
-
-
33746836894
-
Targeted therapy of cancer: New prospectsfor antibodies and immunoconjugates
-
Sharkey RM, Goldenberg DM (2006) Targeted therapy of cancer: new prospectsfor antibodies and immunoconjugates. CA Cancer J Clin 56: 226-243.
-
(2006)
CA Cancer J Clin
, vol.56
, pp. 226-243
-
-
Sharkey, R.M.1
Goldenberg, D.M.2
-
18
-
-
44449085539
-
Paul Ehrlich's magic bullet concept: 100 years ofprogress
-
Strebhardt K, Ullrich A (2008) Paul Ehrlich's magic bullet concept: 100 years ofprogress. Nat Rev Cancer 8: 473-480.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 473-480
-
-
Strebhardt, K.1
Ullrich, A.2
-
19
-
-
73349121354
-
ClinicalCancer Advances 2009: Major research advances in cancer treatment,prevention, and screening-a report from the American Society of ClinicalOncology
-
Petrelli NJ, Winer EP, Brahmer J, Dubey S, Smith S, et al. (2009) ClinicalCancer Advances 2009: major research advances in cancer treatment,prevention, and screening-a report from the American Society of ClinicalOncology. J Clin Oncol 27: 6052-6069.
-
(2009)
J Clin Oncol
, vol.27
, pp. 6052-6069
-
-
Petrelli, N.J.1
Winer, E.P.2
Brahmer, J.3
Dubey, S.4
Smith, S.5
-
20
-
-
69949151386
-
Factors underlying sensitivity of cancers tosmall-molecule kinase inhibitors
-
Janne PA, Gray N, Settleman J (2009) Factors underlying sensitivity of cancers tosmall-molecule kinase inhibitors. Nat Rev Drug Discov 8: 709-723.
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 709-723
-
-
Janne, P.A.1
Gray, N.2
Settleman, J.3
-
21
-
-
73949087586
-
Personalized cancer therapy with selectivekinase inhibitors: An emerging paradigm in medical oncology
-
McDermott U, Settleman J (2009) Personalized cancer therapy with selectivekinase inhibitors: an emerging paradigm in medical oncology. J Clin Oncol 27:5650-5659.
-
(2009)
J Clin Oncol
, vol.27
, pp. 5650-5659
-
-
McDermott, U.1
Settleman, J.2
-
22
-
-
75149130051
-
Targeting the cancer kinome throughpolypharmacology
-
Knight ZA, Lin H, Shokat KM (2010) Targeting the cancer kinome throughpolypharmacology. Nat Rev Cancer 10: 130-137.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 130-137
-
-
Knight, Z.A.1
Lin, H.2
Shokat, K.M.3
-
23
-
-
58349117246
-
Thecancer translational research informatics platform
-
McConnell P, Dash RC, Chilukuri R, Pietrobon R, Johnson K, et al. (2008) Thecancer translational research informatics platform. BMC Med Inform DecisMak 8: 60.
-
(2008)
BMC Med Inform DecisMak
, vol.8
, pp. 60
-
-
McConnell, P.1
Dash, R.C.2
Chilukuri, R.3
Pietrobon, R.4
Johnson, K.5
-
24
-
-
73949153082
-
Supporting the design oftranslational clinical studies through the generation and verification of conceptualknowledge-anchored hypotheses
-
Payne PR, Borlawsky TB, Kwok A, Greaves AW (2008) Supporting the design oftranslational clinical studies through the generation and verification of conceptualknowledge-anchored hypotheses. AMIA Annu Symp Proc. pp 566-570.
-
(2008)
AMIA Annu Symp Proc
, pp. 566-570
-
-
Payne, P.R.1
Borlawsky, T.B.2
Kwok, A.3
Greaves, A.W.4
-
25
-
-
47249128234
-
ArrayWiki: An enablingtechnology for sharing public microarray data repositories and meta-analyses
-
Stokes TH, Torrance JT, Li H, Wang MD (2008) ArrayWiki: an enablingtechnology for sharing public microarray data repositories and meta-analyses.BMC Bioinformatics 9 Suppl 6: S18.
-
(2008)
BMC Bioinformatics 9 Suppl
, vol.6
-
-
Stokes, T.H.1
Torrance, J.T.2
Li, H.3
Wang, M.D.4
-
26
-
-
75549089967
-
TheUCSC Genome Browser database: Update 2010
-
Rhead B, Karolchik D, Kuhn RM, Hinrichs AS, Zweig AS, et al. (2010) TheUCSC Genome Browser database: update 2010. Nucleic Acids Res 38:D613-619.
-
(2010)
Nucleic Acids Res
, vol.38
-
-
Rhead, B.1
Karolchik, D.2
Kuhn, R.M.3
Hinrichs, A.S.4
Zweig, A.S.5
-
27
-
-
3042734655
-
Computational knowledge integration in biopharmaceutical research
-
Ficenec D, Osborne M, Pradines J, Richards D, Felciano R, et al. (2003) Computational knowledge integration in biopharmaceutical research. BriefBioinform 4: 260-278.
-
(2003)
BriefBioinform
, vol.4
, pp. 260-278
-
-
Ficenec, D.1
Osborne, M.2
Pradines, J.3
Richards, D.4
Felciano, R.5
-
28
-
-
67650382229
-
Recommendations from the 2008 International Summit on Proteomics DataRelease and Sharing Policy: The Amsterdam principles
-
Rodriguez H, Snyder M, Uhlen M, Andrews P, Beavis R, et al. (2009) Recommendations from the 2008 International Summit on Proteomics DataRelease and Sharing Policy: the Amsterdam principles. J Proteome Res 8:3689-3692.
-
(2009)
J Proteome Res
, vol.8
, pp. 3689-3692
-
-
Rodriguez, H.1
Snyder, M.2
Uhlen, M.3
Andrews, P.4
Beavis, R.5
-
29
-
-
71049128316
-
An informaticssupported web-based data annotation and query tool to expedite translationalresearch for head and neck malignancies
-
Amin W, Kang HP, Egloff AM, Singh H, Trent K, et al. (2009) An informaticssupported web-based data annotation and query tool to expedite translationalresearch for head and neck malignancies. BMC Cancer 9: 396.
-
(2009)
BMC Cancer
, vol.9
, pp. 396
-
-
Amin, W.1
Kang, H.P.2
Egloff, A.M.3
Singh, H.4
Trent, K.5
-
30
-
-
63849195206
-
Creating reference datasets forsystems biology applications using text mining
-
Krallinger M, Rojas AM, Valencia A (2009) Creating reference datasets forsystems biology applications using text mining. Ann N Y Acad Sci 1158: 14-28.
-
(2009)
Ann N Y Acad Sci
, vol.1158
, pp. 14-28
-
-
Krallinger, M.1
Rojas, A.M.2
Valencia, A.3
-
31
-
-
74049122828
-
Cancer systems biology: A networkmodeling perspective
-
Kreeger PK, Lauffenburger DA (2010) Cancer systems biology: a networkmodeling perspective. Carcinogenesis 31: 2-8.
-
(2010)
Carcinogenesis
, vol.31
, pp. 2-8
-
-
Kreeger, P.K.1
Lauffenburger, D.A.2
-
32
-
-
70349182290
-
Asystems biology view of cancer
-
Laubenbacher R, Hower V, Jarrah A, Torti SV, Shulaev V, et al. (2009) Asystems biology view of cancer. Biochim Biophys Acta 1796: 129-139.
-
(2009)
Biochim Biophys Acta
, vol.1796
, pp. 129-139
-
-
Laubenbacher, R.1
Hower, V.2
Jarrah, A.3
Torti, S.V.4
Shulaev, V.5
-
34
-
-
33749335282
-
TheConnectivity Map: Using gene-expression signatures to connect small molecules,genes, and disease
-
Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, et al. (2006) TheConnectivity Map: using gene-expression signatures to connect small molecules,genes, and disease. Science 313: 1929-1935.
-
(2006)
Science
, vol.313
, pp. 1929-1935
-
-
Lamb, J.1
Crawford, E.D.2
Peck, D.3
Modell, J.W.4
Blat, I.C.5
-
35
-
-
55349104084
-
Genomic-scale prioritization of drug targets: The TDR Targets database
-
Aguero F, Al-Lazikani B, Aslett M, Berriman M, Buckner FS, et al. (2008) Genomic-scale prioritization of drug targets: the TDR Targets database. NatRev Drug Discov 7: 900-907.
-
(2008)
NatRev Drug Discov
, vol.7
, pp. 900-907
-
-
Aguero, F.1
Al-Lazikani, B.2
Aslett, M.3
Berriman, M.4
Buckner, F.S.5
-
36
-
-
75549090848
-
Update of TTD:Therapeutic Target Database
-
Zhu F, Han B, Kumar P, Liu X, Ma X, et al. (2010) Update of TTD:Therapeutic Target Database. Nucleic Acids Res 38: D787-791.
-
(2010)
Nucleic Acids Res
, vol.38
-
-
Zhu, F.1
Han, B.2
Kumar, P.3
Liu, X.4
Ma, X.5
-
37
-
-
77953001581
-
Representation and analysis of molecular networks involvingdiseases and drugs
-
Kanehisa M (2009) Representation and analysis of molecular networks involvingdiseases and drugs. Genome Inform 23: 212-213.
-
(2009)
Genome Inform
, vol.23
, pp. 212-213
-
-
Kanehisa, M.1
-
38
-
-
38549151817
-
DrugBank:A knowledgebase for drugs, drug actions and drug targets
-
Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, et al. (2008) DrugBank:a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 36:D901-906.
-
(2008)
Nucleic Acids Res
, vol.36
-
-
Wishart, D.S.1
Knox, C.2
Guo, A.C.3
Cheng, D.4
Shrivastava, S.5
-
39
-
-
1542530873
-
Web-based tools for mining the NCIdatabases for anticancer drug discovery
-
Fang X, Shao L, Zhang H, Wang S (2004) Web-based tools for mining the NCIdatabases for anticancer drug discovery. J Chem Inf Comput Sci 44: 249-257.
-
(2004)
J Chem Inf Comput Sci
, vol.44
, pp. 249-257
-
-
Fang, X.1
Shao, L.2
Zhang, H.3
Wang, S.4
-
42
-
-
36048956411
-
Management of cutaneous melanoma: A publichealth and individual patient care perspective
-
Wang SQ, Halpern AC (2007) Management of cutaneous melanoma: a publichealth and individual patient care perspective. Adv Dermatol 23: 81-98.
-
(2007)
Adv Dermatol
, vol.23
, pp. 81-98
-
-
Wang, S.Q.1
Halpern, A.C.2
-
43
-
-
67449150231
-
Increasingburden of melanoma in the United States
-
Linos E, Swetter SM, Cockburn MG, Colditz GA, Clarke CA (2009) Increasingburden of melanoma in the United States. J Invest Dermatol 129: 1666-1674.
-
(2009)
J Invest Dermatol
, vol.129
, pp. 1666-1674
-
-
Linos, E.1
Swetter, S.M.2
Cockburn, M.G.3
Colditz, G.A.4
Clarke, C.A.5
-
44
-
-
36849030243
-
Management of metastatic melanoma
-
Tawbi HA, Kirkwood JM (2007) Management of metastatic melanoma. SeminOncol 34: 532-545.
-
(2007)
SeminOncol
, vol.34
, pp. 532-545
-
-
Tawbi, H.A.1
Kirkwood, J.M.2
-
45
-
-
36049014332
-
Treatments for metastatic melanoma: Synthesis of evidence from randomizedtrials
-
Lui P, Cashin R, Machado M, Hemels M, Corey-Lisle PK, et al. (2007) Treatments for metastatic melanoma: synthesis of evidence from randomizedtrials. Cancer Treat Rev 33: 665-680.
-
(2007)
Cancer Treat Rev
, vol.33
, pp. 665-680
-
-
Lui, P.1
Cashin, R.2
Machado, M.3
Hemels, M.4
Corey-Lisle, P.K.5
-
46
-
-
33846682938
-
Chemotherapy for metastaticmelanoma: Time for a change?
-
Gogas HJ, Kirkwood JM, Sondak VK (2007) Chemotherapy for metastaticmelanoma: time for a change? Cancer 109: 455-464.
-
(2007)
Cancer
, vol.109
, pp. 455-464
-
-
Gogas, H.J.1
Kirkwood, J.M.2
Sondak, V.K.3
-
47
-
-
3042666881
-
Anevidence-based staging system for cutaneous melanoma
-
quiz 182-134
-
Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, et al. (2004) Anevidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54:131-149; quiz 182-134.
-
(2004)
CA Cancer J Clin
, vol.54
, pp. 131-149
-
-
Balch, C.M.1
Soong, S.J.2
Atkins, M.B.3
Buzaid, A.C.4
Cascinelli, N.5
-
48
-
-
38449089187
-
Adjuvant therapywith high-dose interferon alpha 2b in patients with high-risk stage IIB/IIImelanoma
-
Kirkwood JM, Tarhini AA, Moschos SJ, Panelli MC (2008) Adjuvant therapywith high-dose interferon alpha 2b in patients with high-risk stage IIB/IIImelanoma. Nat Clin Pract Oncol 5: 2-3.
-
(2008)
Nat Clin Pract Oncol
, vol.5
, pp. 2-3
-
-
Kirkwood, J.M.1
Tarhini, A.A.2
Moschos, S.J.3
Panelli, M.C.4
-
49
-
-
77950576363
-
Interferon Alpha AdjuvantTherapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis
-
Mocellin S, Pasquali S, Rossi CR, Nitti D (2010) Interferon Alpha AdjuvantTherapy in Patients With High-Risk Melanoma: A Systematic Review and Meta-analysis. J Natl Cancer Inst.
-
(2010)
J Natl Cancer Inst
-
-
Mocellin, S.1
Pasquali, S.2
Rossi, C.R.3
Nitti, D.4
-
50
-
-
43649085355
-
The melanoma molecular map project
-
Mocellin S, Rossi CR (2008) The melanoma molecular map project. MelanomaRes 18: 163-165.
-
(2008)
MelanomaRes
, vol.18
, pp. 163-165
-
-
Mocellin, S.1
Rossi, C.R.2
-
52
-
-
39549093107
-
Recent developments in meta-analysis
-
Sutton AJ, Higgins JP (2008) Recent developments in meta-analysis. Stat Med27: 625-650.
-
(2008)
Stat Med27
, pp. 625-650
-
-
Sutton, A.J.1
Higgins, J.P.2
-
53
-
-
21744435569
-
Surveying the literature from animalexperiments: Systematic review and meta-analysis are important contributions
-
Macleod MR, Ebrahim S, Roberts I (2005) Surveying the literature from animalexperiments: systematic review and meta-analysis are important contributions.Bmj 331: 110.
-
(2005)
Bmj
, vol.331
, pp. 110
-
-
Macleod, M.R.1
Ebrahim, S.2
Roberts, I.3
-
54
-
-
0033557255
-
Meta-analysis: Formulating, evaluating, combining, andreporting
-
Normand SL (1999) Meta-analysis: formulating, evaluating, combining, andreporting. Stat Med 18: 321-359.
-
(1999)
Stat Med
, vol.18
, pp. 321-359
-
-
Normand, S.L.1
-
55
-
-
17844365867
-
A method formeta-analysis of molecular association studies
-
Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J (2005) A method formeta-analysis of molecular association studies. Stat Med 24: 1291-1306.
-
(2005)
Stat Med
, vol.24
, pp. 1291-1306
-
-
Thakkinstian, A.1
McElduff, P.2
D'este, C.3
Duffy, D.4
Attia, J.5
-
56
-
-
38949210321
-
Methods for meta-analysis in geneticassociation studies: A review of their potential and pitfalls
-
Kavvoura FK, Ioannidis JP (2008) Methods for meta-analysis in geneticassociation studies: a review of their potential and pitfalls. Hum Genet 123:1-14.
-
(2008)
Hum Genet
, vol.123
, pp. 1-14
-
-
Kavvoura, F.K.1
Ioannidis, J.P.2
|